MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: General Surgery
General Surgery

Beyond Nodal Status: A New Risk Score Predicts Recurrence in Lymph Node-Negative Pancreatic Neuroendocrine Tumors

MedXY Editorial TeamDec 22, 2025
genomic profilingRecurrence Risksurgical oncology

Highlights

Predicting Hidden Risk

Nodal negativity does not equate to a cure; over 10% of patients with lymph node-negative (LN-negative) pancreatic neuroendocrine tumors (PanNETs) experience recurrence within ten years.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Pancreatic Fistula and Intra-abdominal Fluid Collections After Distal Pancreatectomy: Incidence, Clinical Impact, and Management Strategies

General SurgeryNov 1, 2026

Tangential Versus Segmental Portomesenteric Venous Resection in Pancreatic Cancer Surgery: Insights from a Global Cohort Study

General SurgeryOct 31, 2026

Multimodal Prediction in Robotic Surgery: Evaluating the Added Value of Task-Level Kinematic Metrics

General SurgeryOct 30, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story